← Open Payments lookup

DANIEL ARELLANO: Open Payments

NPI 1346552437 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,878 in 18 payments from 12 companies in 2025. Trend: 2023 $1,501 · 2024 $1,374 · 2025 $1,878

Food & beverage: $1,878
CompanyPaymentsAmount
La Jolla Pharmaceutical Company6$509
Merck Sharp & Dohme LLC2$249
ABIOMED1$138
ABBVIE INC.1$125
Alcresta Therapeutics, Inc.1$124
Actelion Pharmaceuticals US, Inc.1$124
Gilead Sciences, Inc.1$122
Mallinckrodt Hospital Products Inc.1$108
Xeris Pharmaceuticals, Inc.1$107
Melinta Therapeutics, LLC1$105

Products named: GIAPREZA, ZERBAXA, EMBLAVEO, RELIZORB, UPTRAVI, Livdelzi, ZEVTERA, TERLIVAZ.

Industry payments across TX — which companies pay providers there.